ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00961883
Recruitment Status : Completed
First Posted : August 19, 2009
Last Update Posted : September 6, 2013
Sponsor:
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
EuroVacc Foundation
Information provided by (Responsible Party):
HIV Vaccine Trials Network

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2013
  Study Completion Date : No date given
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):